Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
April/May 2023
February/March 2023
December 2022/January 2023
October/November 2022
Newsletters
Podcasts
More
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SEARCH
SIGN IN
Subscribe Now
Alzheimer's
Mind
Could sleep issues put you at greater risk for Alzheimer’s-related memory loss? It’s possible, according to a new study. Here are the signs to look for
BY
Erin Prater
Health
Experimental Alzheimer’s drug 35% more effective than placebo: Eli Lilly
BY
The Associated Press
Health
The 2 heirs of makeup mogul Estée Lauder are promising $200 million for Alzheimer’s research
BY
Thalia Beaty
and
The Associated Press
Tech
Researchers used artificial intelligence to detect Alzheimer’s risk with over 90% accuracy and could transform how medicine is practiced
BY
Tristan Bove
Mind
Researchers have hope that a new blood test could detect Alzheimer’s earlier
BY
L'Oreal Thompson Payton
Health
The first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
BY
Matthew Perrone
and
The Associated Press
Health
Congressional investigators say the FDA’s controversial approval of Biogen’s Alzheimer’s drug Aduhelm was ‘rife with irregularities’
BY
Fiona Rutherford
,
Celine Castronuovo
, and others
Health
The next breakthrough in Alzheimer’s research could come from old and ‘cognitively impaired’ Chilean rats
BY
Tristan Bove
Family
They live with Alzheimer’s. Here’s how they want to be treated during the holidays—in their own words
BY
Alexa Mikhail
Mind
Boosting mental and physical activity can keep you sharp as you age
BY
Alexa Mikhail
Mind
Most women don’t know they have a higher risk of Alzheimer’s—and are too busy caring for others to take charge of their health
BY
Alexa Mikhail
MPW
Vaxxinity CEO says the U.S. needs more vaccine options
BY
Marco Quiroz-Gutierrez
International
Alzheimer’s villages could be the answer to the rising cases—and cost—of dementia
BY
Sophie Mellor
Newsletters
The never ending Biogen Alzheimer’s drug saga delivers yet another twist
BY
Sy Mukherjee
Health
Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
BY
Sy Mukherjee
Load More
Most Popular
Lifestyle
America’s national beer could soon be Mexican as Memorial Day weekend sales drop plunges Bud Light further into crisis
BY
Christiaan Hetzner
Commentary
The return-to-office wars could end in a stalemate as we all reach the same conclusion about what the flexible future...
BY
Terri R. Kurtzberg
and
Mason Ameri
Personal Finance
Getting rich is ‘surprisingly simple’ if you follow a 3-step strategy, says an expert on self-made wealth
BY
Jane Thier